[Form 4] Wendy's Co Insider Trading Activity
Rhea-AI Filing Summary
Wendy's Co (WEN) Chief People Officer Matthew Coley O'Brien received multiple restricted stock units and dividend-equivalent units on September 16, 2025. The Form 4 reports issuance of 1,601 restricted stock units and associated dividend-equivalent units that convert to common stock: grants of 264, 27, 72, 206 and 1,032 units, each representing a right to one share. These awards carry tax withholding rights and vest on specified future dates between March 1, 2026 and August 12, 2028, subject to continued employment. Following the reported transactions Mr. O'Brien beneficially owned 110,929 shares.
Positive
- Officer alignment with shareholders via issuance of restricted stock units that convert to common shares upon vesting
- Clear vesting schedule and totals disclosed, enabling transparency about future potential share issuance (total reported holdings 110,929 shares)
Negative
- None.
Insights
TL;DR: Officer received time-based restricted stock units and dividend equivalents, increasing reported holdings to 110,929 shares.
The Form 4 documents routine equity compensation for a named executive officer: restricted stock units with tandem dividend-equivalent rights and tax-withholding provisions. Vesting is time-based across multiple dates from March 1, 2026 through August 12, 2028 and is contingent on continued employment. The grants are disclosed as acquisitions on September 16, 2025 and increase the officer's reported beneficial ownership. This is a governance/compensation disclosure rather than an indicator of a change in control or a market-moving transaction.
TL;DR: Non-derivative awards add 1,601 shares to reported holdings; no exercise price and vesting schedules disclosed.
The transaction entries show restricted stock units granted with $0 price and accompanying dividend-equivalent units. The filings list specific tranche sizes—264, 27, 72, 206 and 1,032 units—with vesting installments and full-vesting dates noted in the explanatory section. The disclosure is precise on share counts and vesting conditions, allowing investors to model future dilution timing but does not include company-level financial impacts in this filing.